Pharmabiz2h
Innate Pharma gets US FDA clearance to begin phase 1 study of Nectin-4 ADC, IPH4502 to treat solid tumours
Innate Pharma gets US FDA clearance to begin phase 1 study of Nectin-4 ADC, IPH4502 to treat solid tumours: Marseille, France Tuesday, September 24, 2024, 16:00 Hrs [IST] Innate P ...
Pharmabiz1h
Nicox, and Glaukos ink exclusive NCX 1728 research and global licensing option agreement
Nicox SA, an international ophthalmology company, announced that it has entered into an exclusive research and license option agreement with Glaukos Corporation for NCX 1728, Nicox’s novel nitric ...
Pharmabiz4h
Kerala IPA to honour four pharmacy professionals tomorrow as part of World Pharmacist Day celebration
Kerala IPA to honour four pharmacy professionals tomorrow as part of World Pharmacist Day celebration: Our Bureau, Chennai Tuesday, September 24, 2024, 13:30 Hrs [IST] The Kerala ...
Pharmabiz3h
Telix Pharma to acquire RLS to expand North American manufacturing and distribution platform
Telix Pharma to acquire RLS to expand North American manufacturing and distribution platform: Melbourne, Australia Tuesday, September 24, 2024, 15:00 Hrs [IST] Telix Pharmaceutica ...
Pharmabiz5h
Antengene receives Thailand FDA approval to commercialize Xpovio in Thailand
Antengene receives Thailand FDA approval to commercialize Xpovio in Thailand: Shanghai Tuesday, September 24, 2024, 13:00 Hrs [IST] Antengene Corporation Limited, a leading innova ...
Pharmabiz7h
Teva Pharma announces long term efficacy and safety of deutetrabenazine in European patients with debilitating movement disorder tardive dyskinesia
Teva Pharma announces long term efficacy and safety of deutetrabenazine in European patients with debilitating movement disorder tardive dyskinesia: Tel Aviv, Israel Tuesday, Sept ...
Pharmabiz6h
US FDA approves anti-CD38 therapy, Sarclisa in combo with standard-of-care treatment for adult patients with NDMM who are not eligible for transplant
US FDA approves anti-CD38 therapy, Sarclisa in combo with standard-of-care treatment for adult patients with NDMM who are not eligible for transplant: Paris Tuesday, September 24, ...
Pharmabiz7h
API prices to remain weak for India in FY25, says Ind-Ra report
API prices to remain weak for India in FY25, says Ind-Ra report: Our Bureau, New Delhi Tuesday, September 24, 2024, 10:10 Hrs [IST] Active pharmaceutical ingredient (API) prices a ...
Pharmabiz5h
Arya Vaidya Pharmacy in Coimbatore launches ‘Prachin Vriksha Ayurveda Chikitsa’ to rejuvenate trees
Arya Vaidya Pharmacy in Coimbatore launches ‘Prachin Vriksha Ayurveda Chikitsa’ to rejuvenate trees: Our Bureau, Chennai Tuesday, September 24, 2024, 12:15 Hrs [IST] The Arya ...
Pharmabiz10h
Hyderabad to host landmark awareness programme on NABL accreditation for medical imaging facilities
Hyderabad to host landmark awareness programme on NABL accreditation for medical imaging facilities: Shardul Nautiyal, Mumbai ...
Pharmabiz10h
NBEMS defers DPEE, academics want uniform academic calendar for D Pharm course at all India level
Peethaambaran Kunnathoor, Chennai Tuesday, September 24, 2024, 08:00 Hrs [IST] ...
Pharmabiz10h
Biotech industry hopes new Vigyan Dhara of Rs. 10,000 crore to strengthen research and woo talent
The biotechnology industry hopes the new Vigyan Dhara initiative of the Union government with a Rs. 10,000 crore outlay will result in better fund utilisation, and improve efficiency with its support ...